SCHEMBL6984534

SCHEMBL6984534

O=S(=O)(Cc1ccccc1)Nc1ccc2c(c1)CCCN2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLNR O43193 1/20 0.53
AR P10275 1/20 0.51
CYP19A1 P11511 1/20 0.49
KMT2A Q03164 1/20 0.48
BRD4 O60885 2/20 0.46
PGR P06401 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
AURKA O14965 1/20 0.44
AURKB Q96GD4 1/20 0.44
HPGD P15428 1/20 0.44
HDAC1 Q13547 1/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
SGK1 O00141 1/20 0.43
FSHR P23945 1/20 0.42
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984749 0.90 MLNR (0.50) MLNRARCYP19A1KMT2ABRD4
SCHEMBL29817718 0.88 LMNA (0.44) MLNRARCYP19A1BRD4CA12
SCHEMBL28156613 0.88 LMNA (0.44) MLNRARCYP19A1BRD4CA12
SCHEMBL6984820 0.81 HTR6 (0.61) KMT2ABRD4CA12CA1CA2
SCHEMBL6985547 0.78 HTR6 (0.41) MLNRARBRD4CA12CA1
SCHEMBL6981244 0.78 BRD4 (0.49) MLNRARKMT2ABRD4CA12
SCHEMBL11698451 0.77 CA12 (0.54) CA12CA1CA2CA9HPGD
SCHEMBL31681377 0.77 EIF2AK2 (0.54) MLNRBRD4CA12CA1CA2
SCHEMBL6981447 0.75 NPC1 (0.68) KMT2AAURKAHPGDKDM4EMAPT
SCHEMBL6980011 0.74 BRD4 (0.58) KMT2ABRD4CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed